These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1580296)

  • 1. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic.
    Samet JH; Libman H; Steger KA; Dhawan RK; Chen J; Shevitz AH; Dewees-Dunk R; Levenson S; Kufe D; Craven DE
    Am J Med; 1992 May; 92(5):495-502. PubMed ID: 1580296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zidovudine therapy in an inner city population.
    Samuels JE; Hendrix J; Hilton M; Marantz PR; Sloan V; Small CB
    J Acquir Immune Defic Syndr (1988); 1990; 3(9):877-83. PubMed ID: 2384864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral medication compliance in patients with AIDS.
    Frick PA; Gal P; Lane TW; Sewell PC
    AIDS Patient Care STDS; 1998 Jun; 12(6):463-70. PubMed ID: 11361994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cohort study of drug users' compliance with zidovudine treatment.
    Broers B; Morabia A; Hirschel B
    Arch Intern Med; 1994 May; 154(10):1121-7. PubMed ID: 8185425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
    Cox PH; Martin MA; Styer CM; Beall GN
    Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy.
    Smith MY; Rapkin BD; Morrison A; Kammerman S
    J Gen Intern Med; 1997 Apr; 12(4):216-23. PubMed ID: 9127225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of zidovudine for drug misusers infected with human immunodeficiency virus.
    Cowan FM; Jones G; Bingham J; Flegg PJ; MacCallum LR; Whitelaw J; Hargreave D; Gray JA; Welsby PD; Brettle RP
    J Infect; 1989 Jan; 18 Suppl 1():59-66. PubMed ID: 2915141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex.
    Glaser JB; Volpe S; Aguirre A; Simpkins H; Schiffman G
    J Infect Dis; 1991 Oct; 164(4):761-4. PubMed ID: 1894937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue.
    Freeman RC; Rodriguez GM; French JF
    AIDS Educ Prev; 1996 Feb; 8(1):58-71. PubMed ID: 8703641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine.
    Casoli C; Magnani G; Schianchi C; Barchi E; Bertazzoni U
    AIDS; 1990 Aug; 4(8):799-802. PubMed ID: 2261134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
    AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials. AIDS Clinical Trials Group (ACTG).
    Fogelman I; Lim L; Bassett R; Volberding P; Fischl MA; Stanley K; Cotton DJ
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1057-63. PubMed ID: 8083823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of zidovudine antiretroviral therapy in the pathogenesis of acquired immunodeficiency syndrome-related lymphoma.
    Levine AM; Bernstein L; Sullivan-Halley J; Shibata D; Mahterian SB; Nathwani BN
    Blood; 1995 Dec; 86(12):4612-6. PubMed ID: 8541552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group.
    Vella S; Giuliano M; Pezzotti P; Agresti MG; Tomino C; Floridia M; Greco D; Moroni M; Visco G; Milazzo F
    JAMA; 1992 Mar; 267(9):1232-6. PubMed ID: 1538560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating compliance to study medication from serum drug levels: application to an AIDS clinical trial of zidovudine.
    Lim LL
    Biometrics; 1992 Jun; 48(2):619-30. PubMed ID: 1637984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons.
    Stein MD; Piette J; Mor V; Wachtel TJ; Fleishman J; Mayer KH; Carpenter CC
    J Gen Intern Med; 1991; 6(1):35-40. PubMed ID: 1999744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.